- Home
- ATNI vs GNFT Comparison
ATNI vs GNFT Comparison
Compare ATNI & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNI
- GNFT
- Stock Information
- Founded
- ATNI 1987
- GNFT 1999
- Country
- ATNI United States
- GNFT France
- Employees
- ATNI N/A
- GNFT N/A
- Industry
- ATNI Telecommunications Equipment
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATNI Telecommunications
- GNFT Health Care
- Exchange
- ATNI Nasdaq
- GNFT Nasdaq
- Market Cap
- ATNI 226.4M
- GNFT 216.7M
- IPO Year
- ATNI 1991
- GNFT 2019
- Fundamental
- Price
- ATNI $19.84
- GNFT $4.11
- Analyst Decision
- ATNI
- GNFT Strong Buy
- Analyst Count
- ATNI 0
- GNFT 2
- Target Price
- ATNI N/A
- GNFT $10.00
- AVG Volume (30 Days)
- ATNI 44.1K
- GNFT 7.2K
- Earning Date
- ATNI 11-05-2025
- GNFT 09-22-2025
- Dividend Yield
- ATNI 5.59%
- GNFT N/A
- EPS Growth
- ATNI N/A
- GNFT N/A
- EPS
- ATNI N/A
- GNFT N/A
- Revenue
- ATNI $724,308,000.00
- GNFT $52,994,715.00
- Revenue This Year
- ATNI $1.57
- GNFT $3.14
- Revenue Next Year
- ATNI $2.09
- GNFT N/A
- P/E Ratio
- ATNI N/A
- GNFT N/A
- Revenue Growth
- ATNI N/A
- GNFT N/A
- 52 Week Low
- ATNI $13.76
- GNFT $2.55
- 52 Week High
- ATNI $23.60
- GNFT $5.35
- Technical
- Relative Strength Index (RSI)
- ATNI 80.69
- GNFT 51.24
- Support Level
- ATNI $14.16
- GNFT $3.77
- Resistance Level
- ATNI $19.37
- GNFT $4.24
- Average True Range (ATR)
- ATNI 1.04
- GNFT 0.17
- MACD
- ATNI 0.63
- GNFT -0.01
- Stochastic Oscillator
- ATNI 100.00
- GNFT 60.26
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.